COVID-19: Male Patients with 3 times higher on severe illness

COVID-19: Male Patients with 3 times higher on severe illness

COVID-19: Male Patients with 3 times higher on severe illness . The latest international research says that male patients with new coronavirus pneumonia are at higher risk of severe illness.

On the 9th, Springer Nature’s international academic journal “Nature-Communications” published an epidemiological research paper online, stating that a global analysis covering more than 3 million cases of COVID-19 pneumonia showed that male patients with COVID-19 pneumonia need to receive severe illness The possibility of monitoring is almost three times that of female patients.

The latest study also found that while male patients with COVID-19 pneumonia are at a higher risk of severe illness, male patients are at a higher risk of death from COVID-19 pneumonia.

The paper also reminded that evidence shows that male patients with COVID-19 pneumonia have a high disease severity, but this has not been confirmed by large-scale global data analysis.

Corresponding authors of the paper, Kate Webb, University of Cape Town, South Africa, and Claire Deakin, University College London, UK, and colleagues conducted a meta-analysis to investigate whether gender is the cause of COVID-19 infection and mortality from COVID-19 A risk factor.

They analyzed 92 reports from government websites and published literature from January 1, 2020 to June 1, 2020, covering a total of 3,111,714 cases of recorded gender, with cases from 46 countries and 44 states in the United States . The researchers found that there was no difference in the proportion of male and female patients infected with the new coronavirus in the analyzed samples. However, in the sample, the probability of male patients entering the intensive care unit due to COVID-19 pneumonia is higher (2.84 times that of women), and the probability of men dying from COVID-19 pneumonia is 1.39 times that of women.

The authors of the paper believe that the differences in immune responses of different sexes may be an influencing factor for the results they observe. However, other biological factors and gender-related comorbidities may also have an impact. They pointed out that although further research is needed, these data are still of great significance for the clinical management and mitigation strategies of COVID-19 pneumonia.